XOMA XOMA Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: XOMA

Price (delayed)

$25.55

Market cap

$297.04M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.04

Enterprise value

$268.04M

XOMA has built a significant portfolio of products that are licensed to and being developed by other biotechnology and pharmaceutical companies. The Company's portfolio of partner-funded programs spans multiple stages ...

Highlights
The company's quick ratio has surged by 143% QoQ but it fell by 7% YoY
The revenue has contracted by 21% YoY but it has grown by 8% from the previous quarter
XOMA's net income has shrunk by 139% YoY and by 53% QoQ
The EPS has plunged by 104% YoY and by 44% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.xoma.com
Peers: EBS NVS TEVA PFE

Key stats

What are the main financial stats of XOMA
Market
Shares outstanding
11.63M
Market cap
$297.04M
Enterprise value
$268.04M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.31
Price to sales (P/S)
61.6
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
56.33
Earnings
Revenue
$4.76M
EBIT
-$40.26M
EBITDA
-$39.24M
Free cash flow
-$18.87M
Per share
EPS
-$4.04
Free cash flow per share
-$1.64
Book value per share
$7.72
Revenue per share
$0.41
TBVPS
$20.43
Balance sheet
Total assets
$234.3M
Total liabilities
$145.58M
Debt
$124.45M
Equity
$88.72M
Working capital
$149.81M
Liquidity
Debt to equity
1.4
Current ratio
8.68
Quick ratio
7.93
Net debt/EBITDA
0.74
Margins
EBITDA margin
-824.8%
Gross margin
100%
Net margin
-858.2%
Operating margin
-546.9%
Efficiency
Return on assets
-30%
Return on equity
-44.2%
Return on invested capital
-41.5%
Return on capital employed
-18.7%
Return on sales
-846.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

XOMA stock price

How has the XOMA stock price performed over time
Intraday
-0.35%
1 week
3.9%
1 month
6.46%
1 year
40.54%
YTD
38.11%
QTD
6.24%

Financial performance

How have XOMA's revenue and profit performed over time
Revenue
$4.76M
Gross profit
$4.76M
Operating income
-$26.02M
Net income
-$40.83M
Gross margin
100%
Net margin
-858.2%
XOMA's net income has shrunk by 139% YoY and by 53% QoQ
XOMA's operating margin has plunged by 89% YoY but it has increased by 14% from the previous quarter
The operating income has contracted by 49% YoY but it has grown by 7% from the previous quarter
The net margin has declined by 42% since the previous quarter

Growth

What is XOMA's growth rate over time

Valuation

What is XOMA stock price valuation
P/E
N/A
P/B
3.31
P/S
61.6
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
56.33
The EPS has plunged by 104% YoY and by 44% from the previous quarter
XOMA's price to book (P/B) is 66% more than its last 4 quarters average of 2.0 but 8% less than its 5-year quarterly average of 3.6
The company's equity fell by 28% YoY and by 16% QoQ
The stock's P/S is 141% above its 5-year quarterly average of 25.6 and 19% above its last 4 quarters average of 51.8
The revenue has contracted by 21% YoY but it has grown by 8% from the previous quarter

Efficiency

How efficient is XOMA business performance
The ROS has plunged by 198% YoY and by 40% from the previous quarter
XOMA's ROE has plunged by 158% YoY and by 56% from the previous quarter
The return on assets has dropped by 99% year-on-year and by 22% since the previous quarter
The company's return on invested capital has shrunk by 51% YoY and by 2.2% QoQ

Dividends

What is XOMA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for XOMA.

Financial health

How did XOMA financials performed over time
XOMA's total assets is 61% greater than its total liabilities
XOMA's current ratio has surged by 160% since the previous quarter but it is down by 3.3% year-on-year
The company's quick ratio has surged by 143% QoQ but it fell by 7% YoY
The debt is 40% greater than the equity
The company's equity fell by 28% YoY and by 16% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.